Excellent posttransplant survival for patients with nonalcoholic steatohepatitis in the United States.
about
Treating morbid obesity in cirrhosis: A quest of holy grailPerspectives on Nonalcoholic Fatty Liver Disease: An Overview of Present and Future TherapiesNAFLD and liver transplantation: Current burden and expected challenges.Early Intervention With Live Donor Liver Transplantation Reduces Resource Utilization in NASH: The Toronto ExperienceClinical differences between alcoholic liver disease and nonalcoholic fatty liver disease.The relevance of liver histology to predicting clinically meaningful outcomes in nonalcoholic steatohepatitis.Liver transplantation and non-alcoholic fatty liver disease.Temporal trends of nonalcoholic fatty liver disease-related hepatocellular carcinoma in the veteran affairs population.Morbid obesity in liver transplant recipients adversely affects longterm graft and patient survival in a single-institution analysisLiver transplantation in adults: Choosing the appropriate timingEquivalent survival following liver transplantation in patients with non-alcoholic steatohepatitis compared with patients with other liver diseasesNonalcoholic fatty liver: optimizing pretransplant selection and posttransplant care to maximize survival.Dendritic cells limit fibroinflammatory injury in nonalcoholic steatohepatitis in mice.CXCL10-Mediates Macrophage, but not Other Innate Immune Cells-Associated Inflammation in Murine Nonalcoholic SteatohepatitisNon-alcoholic fatty liver disease and liver transplantation: outcomes and advances.Impact of renal impairment on cardiovascular disease mortality after liver transplantation for nonalcoholic steatohepatitis cirrhosisSimple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver diseaseNonalcoholic Fatty Liver Disease: Key Considerations Before and After Liver Transplantation.Assessment of inflammation and fibrosis in non-alcoholic fatty liver disease by imaging-based techniques.Evolution of nonalcoholic fatty liver disease recurrence after liver transplantation.Cardiovascular risk, atherosclerosis and metabolic syndrome after liver transplantation: a mini review.Non-alcoholic fatty liver disease following liver transplantation: a clinical review.Piloting a multidisciplinary clinic for the management of non-alcoholic fatty liver disease: initial 5-year experience.Weighing the risks: Morbid obesity and diabetes are associated with increased risk of death on the liver transplant waiting list.Cardiovascular mortality among liver transplant recipients with nonalcoholic steatohepatitis in the United States-a retrospective study.Current challenges and future directions for liver transplantation.Pre-clinical and clinical investigations of metabolic zonation in liver diseases: The potential of microphysiology systems.Liver Transplantation for Nonalcoholic Steatohepatitis in the US: Temporal Trends and Outcomes.The role of extended criteria donors in liver transplantation for nonalcoholic steatohepatitis.Modulation of IKKβ/NF-κB and TGF-β1/Smad via Fuzheng Huayu recipe involves in prevention of nutritional steatohepatitis and fibrosis in mice.Is disease recurrence still relevant to graft survival?Weight gain after orthotopic liver transplantation: is nonalcoholic fatty liver disease cirrhosis a risk factor for greater weight gain?Weight loss interventions for morbidly obese patients with compensated cirrhosis: a Markov decision analysis model.It is more than just size: obesity and transplantation.Mixed Lineage Kinase 3 Mediates the Induction of CXCL10 by a STAT1-Dependent Mechanism During Hepatocyte Lipotoxicity.Nonalcoholic fatty liver disease and liver transplantation - Where do we stand?Liver Transplantation (LT) for Cryptogenic Cirrhosis (CC) and Nonalcoholic Steatohepatitis (NASH) Cirrhosis: Data from the Scientific Registry of Transplant Recipients (SRTR): 1994 to 2016
P2860
Q26775811-A6FD7C83-39A1-46E5-AB09-ED1F9175294EQ30234444-CEE9BFD2-5491-4A07-AB35-4E34A8E0D022Q30248646-02478896-1604-4F90-B556-9ECF99E37620Q33779040-9156AD98-0B7F-47A5-9B3E-A9B4B4659646Q33886948-8D9C9435-5B39-438D-B157-DFA7A0AE8306Q34252404-9B1FE15E-A426-473D-B6AA-8E4A3EEE648DQ34499022-EB6999CC-CF1A-463F-9338-75FA1C9EB255Q35096951-BA3619B3-D9A8-4865-99F2-625519B52F1FQ35099266-FA94F220-2530-49D5-8067-313A7AA5E3ABQ36220176-E6F007C7-29A3-4D05-BD5B-4C11B560030AQ36288796-AF16D954-111A-4865-A6E9-8DC44CC4E1CAQ36673799-D1A3C765-BFD8-42CD-B44C-C89EF0820310Q36800214-9BE355DB-743C-4623-A0A2-B87BA32AEB20Q37044406-EBE6EDAF-9E32-489C-8B33-09AB054B96C0Q37439861-AAB9E57F-AEDC-4FE8-87A3-25D05735A774Q37548563-3DC8E05D-2290-4936-BEB2-BE5499DADA26Q37596730-1AB14336-8895-401B-B2C8-482EA4B5D5B8Q37691781-49E1A8BA-ABE0-45A1-92DF-0A7A99C5137AQ37995326-684B08F0-3E68-463A-AEE8-91741EEBD0A2Q38022211-5F7649F8-FE60-47E1-9280-8FAE3738D214Q38103630-79F5381F-26BF-41EE-BCFF-26DE490C0979Q38543105-CB10C888-EB6D-4F82-B87D-5149D03201CBQ38609085-2C0F06DE-9B56-4EF0-882C-337BE73D9DB6Q38670338-3BA48298-D646-40CD-AAE4-80D70F1A26C3Q38722260-DBADA48A-4056-4E1D-A832-295250DFABEBQ38820685-8FEE00BB-0333-4F06-87BB-FC3073B3697FQ39280379-085BB240-AD88-4E87-9012-BF6118F21479Q40108169-D0BC578B-D730-45BA-88FD-32F6A43DEC67Q40610020-92B8C021-16A1-494F-B669-F6F3E5C13C56Q40906850-59E31616-C6CC-4951-B2B8-D1FD4C46654EQ43537358-2CC03060-FA90-4094-B265-1B8AA7D83CACQ43820543-DA2336C4-6FEC-41C8-BA3A-96F4E95E8208Q47218598-9E39B42F-1312-4097-A643-057ED50F73FAQ47224276-D5660F1B-4D79-4B83-AA04-4884957E2612Q48161638-410E38DF-48A6-43FB-B4C7-F8EC20DE99BDQ52584505-2D0BA8DE-5F3E-4FE1-93F4-38971F308656Q58802116-2BFB1F8A-5827-4005-AF95-2F6FBE775A3A
P2860
Excellent posttransplant survival for patients with nonalcoholic steatohepatitis in the United States.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Excellent posttransplant survi ...... epatitis in the United States.
@en
Excellent posttransplant survi ...... epatitis in the United States.
@nl
type
label
Excellent posttransplant survi ...... epatitis in the United States.
@en
Excellent posttransplant survi ...... epatitis in the United States.
@nl
prefLabel
Excellent posttransplant survi ...... epatitis in the United States.
@en
Excellent posttransplant survi ...... epatitis in the United States.
@nl
P2093
P2860
P356
P1476
Excellent posttransplant survi ...... epatitis in the United States.
@en
P2093
Anita Afzali
George N Ioannou
Kristin Berry
P2860
P356
10.1002/LT.22435
P577
2012-01-01T00:00:00Z